Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 568

1.

Comparison of hospitalization rates in patients with community-acquired pneumonia treated with telithromycin for 5 or 7 days or clarithromycin for 10 days.

Tellier G, Chang JR, Asche CV, Lavin B, Stewart J, Sullivan SD.

Curr Med Res Opin. 2004 May;20(5):739-47. Erratum in: Curr Med Res Opin. 2004 Aug;20(8):1331.

PMID:
15140341
[PubMed - indexed for MEDLINE]
2.

Comparison of hospitalization rates in patients with community-acquired pneumonia treated with 10 days of telithromycin or clarithromycin.

Niederman MS, Chang JR, Stewart J, Nusrat R, Nieman RB.

Curr Med Res Opin. 2004 May;20(5):749-56. Erratum in: Curr Med Res Opin. 2004 Aug;20(8):1331.

PMID:
15140342
[PubMed - indexed for MEDLINE]
3.

Hospitalization rates among patients with community-acquired pneumonia treated with telithromycin vs clarithromycin: results from two randomized, double-blind, clinical trials.

Niederman MS, Chang JR, Stewart J, Asche CV, Lavin B, Nusrat R, Sullivan SD.

Curr Med Res Opin. 2004 Jul;20(7):969-80.

PMID:
15265241
[PubMed - indexed for MEDLINE]
4.

Efficacy and tolerability of once-daily oral telithromycin compared with clarithromycin for the treatment of community-acquired pneumonia in adults.

Mathers Dunbar L, Hassman J, Tellier G.

Clin Ther. 2004 Jan;26(1):48-62.

PMID:
14996517
[PubMed - indexed for MEDLINE]
5.
7.
8.

[Pharmacoeconomic analysis of community-acquired pneumonia treatment with telithromycin or clarithromycin].

Rubio-Terrés C, Cots JM, Domínguez-Gil A, Herreras A, Sánchez Gascón F, Chang J, Trilla A.

Rev Esp Quimioter. 2003 Sep;16(3):295-303. Spanish.

PMID:
14702121
[PubMed - indexed for MEDLINE]
Free Article
9.

Efficacy and tolerability of once-daily telithromycin compared with high-dose amoxicillin for treatment of community-acquired pneumonia.

Hagberg L, Torres A, van Rensburg D, Leroy B, Rangaraju M, Ruuth E.

Infection. 2002 Dec;30(6):378-86.

PMID:
12478329
[PubMed - indexed for MEDLINE]
10.

A prospective, double-blind, multicenter study comparing clarithromycin extended-release with trovafloxacin in patients with community-acquired pneumonia.

Sokol WN Jr, Sullivan JG, Acampora MD, Busman TA, Notario GF.

Clin Ther. 2002 Apr;24(4):605-15.

PMID:
12017405
[PubMed - indexed for MEDLINE]
11.

Evaluation of 5-day therapy with telithromycin, a novel ketolide antibacterial, for the treatment of tonsillopharyngitis.

Norrby SR, Quinn J, Rangaraju M, Leroy B.

Clin Microbiol Infect. 2004 Jul;10(7):615-23.

PMID:
15214873
[PubMed - indexed for MEDLINE]
12.

Clinical and bacteriological outcomes in hospitalised patients with community-acquired pneumonia treated with azithromycin plus ceftriaxone, or ceftriaxone plus clarithromycin or erythromycin: a prospective, randomised, multicentre study.

Tamm M, Todisco T, Feldman C, Garbino J, Blasi F, Hogan P, de Caprariis PJ, Hoepelman IM.

Clin Microbiol Infect. 2007 Feb;13(2):162-71.

PMID:
17328728
[PubMed - indexed for MEDLINE]
13.

Telithromycin 800 mg once daily for seven to ten days is an effective and well-tolerated treatment for community-acquired pneumonia.

Carbon C, Moola S, Velancsics I, Leroy B, Rangaraju M, Decosta P.

Clin Microbiol Infect. 2003 Jul;9(7):691-703.

PMID:
12925111
[PubMed - indexed for MEDLINE]
14.

Telithromycin in the treatment of community-acquired pneumonia: a pooled analysis.

Hagberg L, Carbon C, van Rensburg DJ, Fogarty C, Dunbar L, Pullman J.

Respir Med. 2003 Jun;97(6):625-33.

PMID:
12814146
[PubMed - indexed for MEDLINE]
16.

Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.

Ye X, Sikirica V, Schein JR, Grant R, Zarotsky V, Doshi D, Benson CJ, Riedel AA.

Clin Ther. 2008 Feb;30(2):358-71. doi: 10.1016/j.clinthera.2008.01.023.

PMID:
18343274
[PubMed - indexed for MEDLINE]
17.

Gemifloxacin once daily for 5 days versus 7 days for the treatment of community-acquired pneumonia: a randomized, multicentre, double-blind study.

File TM Jr, Mandell LA, Tillotson G, Kostov K, Georgiev O.

J Antimicrob Chemother. 2007 Jul;60(1):112-20. Epub 2007 May 30.

PMID:
17537866
[PubMed - indexed for MEDLINE]
Free Article
18.

A pooled analysis of telithromycin in the treatment of community-acquired respiratory tract infections in adults.

Carbon C.

Infection. 2003 Oct;31(5):308-17.

PMID:
14556055
[PubMed - indexed for MEDLINE]
19.

Clinical and bacteriologic efficacy of telithromycin in patients with bacteremic community-acquired pneumonia.

Carbon C, van Rensburg D, Hagberg L, Fogarty C, Tellier G, Rangaraju M, Nusrat R.

Respir Med. 2006 Apr;100(4):577-85. Epub 2006 Jan 11. Review.

PMID:
16376537
[PubMed - indexed for MEDLINE]
Free Article
20.

The efficacy and safety of two oral moxifloxacin regimens compared to oral clarithromycin in the treatment of community-acquired pneumonia.

Hoeffken G, Meyer HP, Winter J, Verhoef L; CAP1 Study Group.

Respir Med. 2001 Jul;95(7):553-64.

PMID:
11453311
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk